Fortis Capital Advisors »

Vaneck Vectors Pharmaceutical etf shares owned by Fortis Capital Advisors

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Fortis Capital Advisors from 13F filings

Historical chart of Fortis Capital Advisors investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Fortis Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Fortis Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $517k 4.7k 109.35

More positions owned by Fortis Capital Advisors

NVIDIA Corporation (NVDA)
Invesco QQQ Trust Etf (QQQ)
Schwab Strategic Tr Etf (SCHX)
Spdr S&p 500 Etf Etf (SPY)
Sch Fnd Us Lg Etf schwb fdt us lg (FNDX)
Schwab U.S. Large-Cap Growth ETF Etf (SCHG)
Apple (AAPL)
Schwab Strategic Tr Etf (SCHF)
Ishares Tr Etf (IJR)
Ishares Tr Etf (IVV)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Vanguard Index Fds Etf (VO)
Ishares Etf (EMXC)
Ishares Tr Etf (EFG)

View all positions for Fortis Capital Advisors

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Jane Street
Healthcare Of Ontario Pension Plan Trust Fund
Bnp Paribas Arbitrage, Snc
British Columbia Investment Management Corporation
Employees Retirement System of Texas
Royal Bank of Canada
J.Safra Asset Management
Tower Research Capital
Avalon Trust
Citigroup
Gts Securities
Morgan Stanley
Adamsbrown Wealth Consultants
Bank of America Corporation

View all funds holding Vaneck Vectors Pharmaceutical etf